• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子ER81与致癌性HER2/Neu、Ras或Raf对端粒酶催化亚基的上调作用。

Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.

作者信息

Goueli Basem S, Janknecht Ralf

机构信息

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

Mol Cell Biol. 2004 Jan;24(1):25-35. doi: 10.1128/MCB.24.1.25-35.2004.

DOI:10.1128/MCB.24.1.25-35.2004
PMID:14673140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC303367/
Abstract

One hallmark of tumor formation is the transcriptional upregulation of human telomerase reverse transcriptase, hTERT, and the resultant induction of telomerase activity. However, little is presently understood about how hTERT is differentially activated in tumor cells versus normal somatic cells. Specifically, it is unclear if oncoproteins can directly elicit hTERT expression. To this end, we now show that three oncoproteins, HER2/Neu, Ras, and Raf, stimulate hTERT promoter activity via the ETS transcription factor ER81 and ERK mitogen-activated protein (MAP) kinases. Mutating ER81 binding sites in the hTERT promoter or suppression of ERK MAP kinase-dependent phosphorylation of ER81 rendered the hTERT promoter unresponsive to HER2/Neu. Further, expression of dominant-negative ER81 or inhibition of HER2/Neu significantly attenuated telomerase activity in HER2/Neu-overexpressing SKBR3 breast cancer cells. Moreover, HER2/Neu, Ras, and Raf collaborated with ER81 to enhance endogenous hTERT gene transcription and telomerase activity in hTERT-negative, nonimmortalized BJ foreskin fibroblasts. Accordingly, hTERT expression was increased in HER2/Neu-positive breast tumors and breast tumor cell lines relative to their HER2/Neu-negative counterparts. Collectively, our data elucidated a mechanism whereby three prominent oncoproteins, HER2/Neu, Ras, and Raf, may facilitate tumor formation by inducing hTERT expression in nonimmortalized cells via the transcription factor ER81.

摘要

肿瘤形成的一个标志是人类端粒酶逆转录酶(hTERT)的转录上调以及由此导致的端粒酶活性诱导。然而,目前对于hTERT在肿瘤细胞与正常体细胞中如何被差异激活了解甚少。具体而言,尚不清楚癌蛋白是否能直接引发hTERT表达。为此,我们现在表明,三种癌蛋白HER2/Neu、Ras和Raf通过ETS转录因子ER81和ERK丝裂原活化蛋白(MAP)激酶刺激hTERT启动子活性。突变hTERT启动子中的ER81结合位点或抑制ERK MAP激酶依赖性的ER81磷酸化会使hTERT启动子对HER2/Neu无反应。此外,显性负性ER81的表达或HER2/Neu的抑制显著减弱了HER2/Neu过表达的SKBR3乳腺癌细胞中的端粒酶活性。而且,HER2/Neu、Ras和Raf与ER81协同作用,增强了hTERT阴性、未永生化的BJ包皮成纤维细胞中的内源性hTERT基因转录和端粒酶活性。因此,相对于HER2/Neu阴性的对应物,HER2/Neu阳性的乳腺肿瘤和乳腺肿瘤细胞系中的hTERT表达增加。总体而言,我们的数据阐明了一种机制,即三种突出的癌蛋白HER2/Neu、Ras和Raf可能通过转录因子ER81在未永生化细胞中诱导hTERT表达来促进肿瘤形成。

相似文献

1
Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.转录因子ER81与致癌性HER2/Neu、Ras或Raf对端粒酶催化亚基的上调作用。
Mol Cell Biol. 2004 Jan;24(1):25-35. doi: 10.1128/MCB.24.1.25-35.2004.
2
Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.p300、P/CAF和HER2/Neu对ETS蛋白ER81的乙酰化介导的转录激活作用。
Mol Cell Biol. 2003 Sep;23(17):6243-54. doi: 10.1128/MCB.23.17.6243-6254.2003.
3
Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.ETS转录因子ER81对Her2/neu启动子活性的调控
J Cell Biochem. 2002;86(1):174-83. doi: 10.1002/jcb.10205.
4
HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81.HER2/Neu和TAK1通过ETS蛋白ER81介导的转化生长因子β抑制剂Smad7的上调。
J Biol Chem. 2003 Nov 7;278(45):44377-84. doi: 10.1074/jbc.M307202200. Epub 2003 Aug 28.
5
Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family.端粒酶活性的转录调控:Ets转录因子家族的作用。
Ann N Y Acad Sci. 2007 Oct;1114:36-47. doi: 10.1196/annals.1396.022.
6
Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway.Her2-ER81相关通路对乳腺癌中hTERT的转录激活作用。
Oncol Res. 2009;17(9):413-23. doi: 10.3727/096504009788912507.
7
The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.PEA3 Ets转录因子是HER2/Neu受体酪氨酸激酶的下游靶点。
Oncogene. 1998 Jan 22;16(3):301-10. doi: 10.1038/sj.onc.1201547.
8
HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.HER2/Neu介导的ETS转录因子ER81及其靶基因MMP-1的激活。
Oncogene. 2001 Sep 27;20(43):6215-24. doi: 10.1038/sj.onc.1204820.
9
Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor.上游刺激因子对端粒酶逆转录酶基因活性的调控
Oncogene. 2003 Sep 11;22(39):8042-7. doi: 10.1038/sj.onc.1206847.
10
Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors.Rcl是一种在乳腺肿瘤中上调的新型ETV1/ER81靶基因。
J Cell Biochem. 2008 Oct 15;105(3):866-74. doi: 10.1002/jcb.21884.

引用本文的文献

1
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
2
Association of hTERT expression, Her2Neu, estrogen receptors, progesterone receptors, with telomere length before and at the end of treatment in breast cancer patients.乳腺癌患者治疗前及治疗结束时hTERT表达、人表皮生长因子受体2(Her2Neu)、雌激素受体、孕激素受体与端粒长度的相关性
Front Med (Lausanne). 2024 Aug 12;11:1450147. doi: 10.3389/fmed.2024.1450147. eCollection 2024.
3
Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line.基于植物化合物的治疗方法:研究姜黄素和绿茶提取物对MCF-7乳腺癌细胞系的作用。
J Genet Eng Biotechnol. 2024 Mar;22(1):100339. doi: 10.1016/j.jgeb.2023.100339. Epub 2024 Jan 22.
4
Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.JMJD2B表观遗传调节因子的甲基化对其共激活ETV1和JUN转录因子的能力有不同影响。
Int J Biochem Mol Biol. 2023 Dec 15;14(6):101-115. eCollection 2023.
5
Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis.SET7/9对表观遗传JMJD2D蛋白的甲基化促进前列腺肿瘤发生。
Front Oncol. 2023 Nov 17;13:1295613. doi: 10.3389/fonc.2023.1295613. eCollection 2023.
6
Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of and .转录因子BHLHE40对结直肠癌的促进作用涉及[具体基因1]和[具体基因2]的上调。 (注:原文中“involves upregulation of and.”部分缺失具体内容,这里是根据格式补充了相应表述以便理解。)
Front Oncol. 2023 Feb 20;13:1122238. doi: 10.3389/fonc.2023.1122238. eCollection 2023.
7
Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer.鉴定肿瘤细胞特异性激活端粒酶的机制为特异性阻断人结直肠癌细胞端粒酶提供了治疗机会。
Nucleic Acids Res. 2023 Jan 11;51(1):1-16. doi: 10.1093/nar/gkac479.
8
An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.一项诱导性CRISPR/Cas9筛选将DTX2鉴定为人端粒酶的转录调节因子。
iScience. 2022 Jan 25;25(2):103813. doi: 10.1016/j.isci.2022.103813. eCollection 2022 Feb 18.
9
Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer.转录因子ETV1的类泛素化修饰调节其在前列腺癌中的致癌潜能。
Int J Clin Exp Pathol. 2021 Jul 15;14(7):795-810. eCollection 2021.
10
Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.ETS 转录因子 ETV1 与组蛋白去甲基化酶 JMJD1A 在结直肠癌中的合作。
Int J Oncol. 2020 Dec;57(6):1319-1332. doi: 10.3892/ijo.2020.5133. Epub 2020 Oct 14.

本文引用的文献

1
Multiple tumor suppressor pathways negatively regulate telomerase.多种肿瘤抑制途径对端粒酶起负调控作用。
Cell. 2003 Jun 27;113(7):881-9. doi: 10.1016/s0092-8674(03)00430-6.
2
hTERT mRNA expression correlates with telomerase activity in human breast cancer.人端粒酶逆转录酶(hTERT)信使核糖核酸(mRNA)表达与人乳腺癌中的端粒酶活性相关。
Eur J Surg Oncol. 2003 May;29(4):321-6. doi: 10.1053/ejso.2002.1374.
3
Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1).丝裂原和应激激活蛋白激酶1(MSK1)对ER81转录因子及其共激活因子的调控
Oncogene. 2003 Feb 6;22(5):746-55. doi: 10.1038/sj.onc.1206185.
4
Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.人端粒酶催化亚基hTERT在人乳腺组织中的表达与分布
Anticancer Res. 2002 Nov-Dec;22(6C):4101-7.
5
Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.通过基因组整合的ErbB2启动子报告细胞筛选检测组蛋白去乙酰化酶抑制剂对ErbB2的转录抑制作用。
Mol Cancer Ther. 2002 Apr;1(6):385-92.
6
Rationale for Ras and raf-kinase as a target for cancer therapeutics.将Ras和raf激酶作为癌症治疗靶点的理论依据。
Curr Pharm Des. 2002;8(25):2231-42. doi: 10.2174/1381612023393107.
7
Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A.90 kDa核糖体S6激酶1和蛋白激酶A对ETS转录因子ER81的调控
J Biol Chem. 2002 Nov 8;277(45):42669-79. doi: 10.1074/jbc.M205501200. Epub 2002 Sep 3.
8
Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression.下游E盒介导的人类端粒酶逆转录酶(hTERT)基因转录调控:转录抑制内源性机制的证据
Mol Biol Cell. 2002 Aug;13(8):2585-97. doi: 10.1091/mbc.e01-11-0107.
9
Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.ETS转录因子ER81对Her2/neu启动子活性的调控
J Cell Biochem. 2002;86(1):174-83. doi: 10.1002/jcb.10205.
10
Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter.转录因子ER71的功能分析及其对基质金属蛋白酶-1启动子的激活作用。
Nucleic Acids Res. 2002 Jul 1;30(13):2972-9. doi: 10.1093/nar/gkf390.